TechMediaBreaks Archive - Page 2 of 217

FridayMay 15, 2026 9:10 am

TechMediaBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) Reports First Quarter Revenue Growth, Improved Loss Metrics

Beeline Holdings (NASDAQ: BLNE) reported first-quarter 2026 net revenue of $2.7 million, more than doubling from the prior-year period, driven by loan originations of $85.6 million across 288 loans compared with $39.8 million across 128 loans a year earlier. The company reported a net loss of $5.3 million, improved from $6.9 million in the prior-year quarter, while adjusted EBITDA loss narrowed to $3.0 million from $3.8 million, as Beeline continued expanding its capital-light BeelineEquity platform and reiterated its goal of reaching a $100 million revenue run rate by the end of 2027. To view the full press release, visit https://ibn.fm/Qt5c5…

FridayMay 15, 2026 9:00 am

TechMediaBreaks – A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Secures $30 Million Credit Facility to Scale Smart Cart Production

A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) announced approval for a $30 million commercial line of credit from one of Israel’s largest commercial banks to support large-scale manufacturing and deployment of its Cust2Mate smart shopping carts. Secured by company purchase orders, the non-dilutive financing is expected to accelerate fulfillment of existing orders and global deployment plans while preserving cash resources and avoiding additional equity financing. To view the full press release, visit https://ibn.fm/7w2UX About A2Z Cust2Mate Solutions Corp. A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) makes in-store retail smarter by connecting retailers, brands, and shoppers at the Smart Cart.Cust2Mate transforms everyday shopping…

ThursdayMay 14, 2026 11:58 am

TechMediaBreaks – BluSky AI Inc. (OTCID: BSAI) Launches Regulation A+ Offering to Support AI Infrastructure Expansion

BluSky AI (OTCID: BSAI) announced the launch of a Regulation A+ offering aimed at enabling individual and accredited investors to participate in the company’s planned expansion of its distributed AI infrastructure network, with a minimum investment of $1,000. Proceeds are intended to support development of BluSky AI’s modular AI Factory footprint across the United States, including expansion of its Neocloud compute capacity designed to serve growing demand for large-scale AI training and inference workloads. To view the full press release, visit https://ibn.fm/b1LaI About BluSky AI Inc. Headquartered in Salt Lake City, Utah, BluSky AI Inc. (the “Company” or “BlueSky AI”) is a Neocloud purpose-built for artificial intelligence through rapidly…

ThursdayMay 14, 2026 10:10 am

TechMediaBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Featured in AINewsWire Editorial on Autonomous Warfare Technologies

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced its featured placement in an editorial published by AINewsWire examining the evolving role of autonomous software in modern warfare. The editorial highlights SPARC AI’s software-only platform designed to provide drones with GPS-denied navigation and precision targeting capabilities, addressing growing defense demand for autonomous intelligence systems that can operate effectively in contested electronic warfare environments. To view the full press release, visit https://ibn.fm/keot1 About SPARC AI Inc. SPARC AI is a defence technology company solving one…

ThursdayMay 14, 2026 10:00 am

TechMediaBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Featured in BioMedWire Editorial on Real-Time Intoxication Detection Technologies

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) announced its featured placement in an editorial published by BioMedWire, highlighting emerging opportunities in real-time intoxication detection technologies. The editorial spotlights MindBio’s AI-driven voice analysis platform, which is being developed to detect impairment from brief speech recordings across a range of substances, addressing growing demand for faster, noninvasive and scalable intoxication detection solutions across healthcare, workplace safety and public health applications. To view the full press release, visit https://ibn.fm/1WCqA About MindBio Therapeutics Corp. MindBio is a…

ThursdayMay 14, 2026 9:36 am

TechMediaBreaks – BOXABL, FG Merger II Advance Proposed Business Combination Following SEC Effectiveness of Form S-4

BOXABL and FG Merger II Corp. (NASDAQ: FGMC) announced that the U.S. Securities and Exchange Commission has declared effective the companies’ joint registration statement on Form S-4 related to their proposed business combination, marking a significant milestone in BOXABL’s path to becoming a publicly traded company. Shareholder meetings to approve the transaction are scheduled for June 9, 2026, with closing expected shortly thereafter, subject to customary conditions, after which the combined company is expected to trade on Nasdaq under the ticker symbol BXBL. To view the full press release, visit https://ibn.fm/7fAPl About BOXABL BOXABL is transforming the housing market with its modular building systems…

ThursdayMay 14, 2026 9:30 am

TechMediaBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) to Present Fibromyalgia Real-World Data at ISPOR 2026

Tonix Pharmaceuticals (NASDAQ: TNXP) announced a poster presentation at ISPOR 2026 highlighting findings from a retrospective cohort study analyzing U.S. claims data from adults with fibromyalgia between April 2021 and April 2024. The presentation will feature real-world insights related to fibromyalgia treatment, following the FDA approval of TONMYA(R) in August 2025 and its subsequent U.S. commercial launch in November 2025. To view the full press release, visit https://ibn.fm/A3668 Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals is a fully-integrated, commercial-stage biotechnology company focused on central nervous system (CNS) and immunology treatments in areas of high unmet medical need. TONMYA(TM) (cyclobenzaprine HCl sublingual…

WednesdayMay 13, 2026 11:55 am

TechMediaBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Establishes Permanent Ukraine Operations to Accelerate Overwatch Adoption

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) announced plans to establish permanent operations in Ukraine through a wholly owned subsidiary to accelerate adoption of its Overwatch autonomous mission software across the country’s defense drone market. The expansion includes building an in-country commercial and technical team, opening a physical office, and appointing Greg Daly as chief strategy and mission integration officer to lead execution, as the company works to convert growing engagement with Ukrainian drone manufacturers and operators into recurring software sales while expanding…

WednesdayMay 13, 2026 11:40 am

TechMediaBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Featured in AINewsWire Editorial on Software-Driven Drone Autonomy

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) was featured in AINewsWire editorial coverage examining the accelerating shift toward software-defined autonomous warfare, with the company highlighted for its Overwatch platform designed to provide GPS-denied navigation and precision targeting for low-cost drones operating in contested environments. The editorial emphasizes that while inexpensive drone hardware has become widely available and increasingly central to modern conflict, particularly in active war zones, the software intelligence required for autonomous operation under electronic warfare conditions remains a critical gap SPARC AI is seeking to address. The coverage also positions SPARC AI alongside other defense and…

WednesdayMay 13, 2026 9:10 am

TechMediaBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Spotlighted in BioMedWire Editorial on AI-Driven Impairment Detection

This article has been disseminated on behalf of MindBio Therapeutics Corp. and may include paid advertising. MindBio Therapeutics (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) was featured in BioMedWire editorial coverage highlighting the growing demand for real-time, noninvasive impairment detection technologies, with the company positioned as a differentiated player leveraging artificial intelligence and voice analysis to identify intoxication from brief speech recordings. The editorial underscores the limitations of conventional detection tools such as breathalyzers, blood draws and urine testing, noting MindBio’s focus on scalable, real-time assessment across multiple substances for potential applications in workplace safety, law enforcement, healthcare and public health. The coverage also…

TechMediaWire provides insights and opportunities in tech.

Contact us: (512) 354-7000

TechMediaBreaks